Telescope Innovations Corp.: Telescope Innovations Reports Significant Milestones and Financial Results of Fiscal Year 2025

Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company"), a developer ...

Relevant Gold Corp.: Relevant Gold Recaps Successful 2025 Exploration Season and Positions for Data-Driven 2026 in Wyoming

VANCOUVER, BC / ACCESS Newswire / December 23, 2025 / Relevant Gold Corp. (TSXV:RGC)(OTCQB:RGCCF) ("Relevant Gold" or the "Company") reports that 2025 was a milestone year marked by the first drill te ...

First Quantum Minerals Ltd.: First Quantum Minerals Announces Sale of Cobre Las Cruces

TORONTO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- First Quantum Minerals Ltd. ("First Quantum" or the "Company") (TSX: FM) today announced that its ...

Bausch Health Companies Inc.: Bausch Health Announces Final Results and Expiration of Exchange Offers

LAVAL, QC / ACCESS Newswire / December 23, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") and its subsidiary 1261229 B.C. Ltd. (the "Issuer" and, together with the Company, th ...

Beedie Investments Ltd.: Beedie Investments Ltd. Announces Filing of Updated Early Warning Report in Relation to Metalla

Beedie Investments Ltd. ("Beedie Capital") announces it has completed an internal reorganization (the "Reorganization") of the holdings ...

Michael Gentile: Michael Gentile Announces Filing of Early Warning Report Related to Acquisition of Units of Cascadia Minerals Ltd.

Michael Gentile announces that he has filed an early warning report (the "Report") announcing the acquisition (the "Acquisition") of an aggregate ...

Making Science Unveils 'AWAKE': The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions

The disruption generated by AI enables the acceleration and industrialisation of the creation of internal solutions and start-ups through centres of excellence in Chicago, Madrid and Tbilisi.

Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo Dupix ...

Reviva Pharmaceuticals: Reviva Announces Regulatory Update Regarding the Development of Brilaroxazine for the Treatment of Schizophrenia

Written feedback from FDA pre-NDA meeting includes a recommendation to conduct a second Phase 3 trial to generate additional efficacy and safety data prior to NDA submission of brilaroxazine for the ...

Cyber Security 1 AB: CYBER1 Announces Executive Restructure, With Appointment Of New Chief Executive Officer

Stockholm, Sweden, December 23, 2025, Cyber Security 1 AB ("CYBER1" or "the Company") today announces a restructure of its executive. Chief Executive Officer, Peter Sedin will maintain his position as ...

Westin Acquisition Corp Announces the Separate Trading of its Class A Ordinary Shares and Rights

Westin Acquisition Corp (NASDAQ: WSTNU, the "Company"), a Cayman Islands exempted company, announced that holders of its 5,750,000 units sold in the Company's ...

Wheels Up Advances Fleet Modernization Plan with Strategic Sale-Leaseback Transaction and Satellite Wi-Fi Milestone

Initiatives close out a year focused on fleet transformation, operational excellence, and elevating the customer experience ATLANTA, Dec. 23, 2025 /PRNewswire/ -- ...